411 related articles for article (PubMed ID: 28916189)
1. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
Ramos AR; Elong Edimo W; Erneux C
Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
[TBL] [Abstract][Full Text] [Related]
3. SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells.
Elong Edimo W; Ghosh S; Derua R; Janssens V; Waelkens E; Vanderwinden JM; Robe P; Erneux C
J Cell Sci; 2016 Mar; 129(6):1101-14. PubMed ID: 26826186
[TBL] [Abstract][Full Text] [Related]
4. Lipid phosphatases SKIP and SHIP2 regulate fibronectin-dependent cell migration in glioblastoma.
Ramos AR; Ghosh S; Dedobbeleer M; Robe PA; Rogister B; Erneux C
FEBS J; 2019 Mar; 286(6):1120-1135. PubMed ID: 30695232
[TBL] [Abstract][Full Text] [Related]
5. The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.
Ramos AR; Ghosh S; Erneux C
J Lipid Res; 2019 Feb; 60(2):276-286. PubMed ID: 30194087
[TBL] [Abstract][Full Text] [Related]
6. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.
Davies EM; Kong AM; Tan A; Gurung R; Sriratana A; Bukczynska PE; Ooms LM; McLean CA; Tiganis T; Mitchell CA
Oncogene; 2015 Jul; 34(28):3711-27. PubMed ID: 25241900
[TBL] [Abstract][Full Text] [Related]
7. SHIP2 signaling in normal and pathological situations: Its impact on cell proliferation.
Elong Edimo W; Schurmans S; Roger PP; Erneux C
Adv Biol Regul; 2014 Jan; 54():142-51. PubMed ID: 24091101
[TBL] [Abstract][Full Text] [Related]
8. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.
Ooms LM; Horan KA; Rahman P; Seaton G; Gurung R; Kethesparan DS; Mitchell CA
Biochem J; 2009 Apr; 419(1):29-49. PubMed ID: 19272022
[TBL] [Abstract][Full Text] [Related]
9. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositide phosphatases: just as important as the kinases.
Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
[TBL] [Abstract][Full Text] [Related]
11. The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells.
Edimo WE; Ramos AR; Ghosh S; Vanderwinden JM; Erneux C
Biochem Biophys Res Commun; 2016 Aug; 476(4):508-514. PubMed ID: 27246739
[TBL] [Abstract][Full Text] [Related]
12. The diversity and possible functions of the inositol polyphosphate 5-phosphatases.
Erneux C; Govaerts C; Communi D; Pesesse X
Biochim Biophys Acta; 1998 Dec; 1436(1-2):185-99. PubMed ID: 9838104
[TBL] [Abstract][Full Text] [Related]
13. Loss of OCRL increases ciliary PI(4,5)P
Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
[TBL] [Abstract][Full Text] [Related]
14. Regulation of phosphoinositide signaling by the inositol polyphosphate 5-phosphatases.
Astle MV; Seaton G; Davies EM; Fedele CG; Rahman P; Arsala L; Mitchell CA
IUBMB Life; 2006 Aug; 58(8):451-6. PubMed ID: 16916781
[TBL] [Abstract][Full Text] [Related]
15. Identification of inhibitors of inositol 5-phosphatases through multiple screening strategies.
Pirruccello M; Nandez R; Idevall-Hagren O; Alcazar-Roman A; Abriola L; Berwick SA; Lucast L; Morel D; De Camilli P
ACS Chem Biol; 2014 Jun; 9(6):1359-68. PubMed ID: 24742366
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.
Li H; Marshall AJ
Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol Kinases and Phosphatases in
Nakada-Tsukui K; Watanabe N; Maehama T; Nozaki T
Front Cell Infect Microbiol; 2019; 9():150. PubMed ID: 31245297
[TBL] [Abstract][Full Text] [Related]
18. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
Eramo MJ; Mitchell CA
Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
[TBL] [Abstract][Full Text] [Related]
19. SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts.
Elong Edimo W; Vanderwinden JM; Erneux C
Adv Biol Regul; 2013 Jan; 53(1):28-37. PubMed ID: 23040614
[TBL] [Abstract][Full Text] [Related]
20. SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein.
Awad A; Sar S; Barré R; Cariven C; Marin M; Salles JP; Erneux C; Samuel D; Gassama-Diagne A
Mol Biol Cell; 2013 Jul; 24(14):2171-85. PubMed ID: 23699395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]